Relapsed breast adenorcarcinoma presenting as pulmonary lymphangitic carcinomatosis by KP Loh et al.
POSTER PRESENTATION Open Access
Relapsed breast adenorcarcinoma presenting as
pulmonary lymphangitic carcinomatosis
KP Loh1*, H Ghorab1, S Kosuri2, M Shah2
From International Conference for Healthcare and Medical Students 2011
Dublin, Ireland. 4-5 November 2011
Introduction
Pulmonary lymphagitic carcinomatosis is an entity refer-
ring to diffuse infiltration and obstruction of pulmonary
parenchymal lymphatic channels by a tumour. The most
common malignancies involved are the breasts, lung,
colon and stomach. Previous studies have shown that at
autopsy up to 24% of patients who died of metastatic
breast cancer had pulmonary lymphagitic spread. How-
ever the diagnosis of lymphangitic carcimatosis can be
challenging due to its non-specific symptoms which
include dypsnoea and cough, which occur in a variety of
lung diseases.
Case report
We describe a case of a 84-year old woman who presented
with a 9 months history of progressive exertional dyspnoea
with occasional productive cough. She was subsequently
diagnosed with pulmonary embolism and chronic obstruc-
tive pulmonary disease. However despite treatment her
dypsnoea had progressed to orthopnoea. In addition, she
had a significant past medical history of non-metastatic
breast ductal adenocarcinoma diagnosed 19 years ago for
which she underwent a right mastectomy as well as being
put on tamoxifen for 5 years, she was also diagnosed with
tuberculosis 70 years ago. On physical examination, she
required 4L of oxygen but was otherwise haemodynami-
cally stable. There were decreased breath sounds at the
lung bases bilaterally but more prominent on the right. In
addition, the right middle and lower lobes of the lung
were dull on percussion. Finally auscultation revealed fine
crepitations at the lung bases bilaterally. In terms of inves-
tigations her CXR and CT-PE demonstrated a pleural effu-
sion. She then underwent thoracocentesis, pleural biopsy,
pleurodesis and right wedge resection. Pathology examina-
tion revealed malignant cells stained positive for estrogen
receptor (ER), progesterone receptor (PR) and Gross Cys-
tic Disease Fluid Protein-15 (GCDFP15) confirming lym-
phangitic spread of breast adenorcarcinoma to the lung
parenchyma. She was treated with paclitaxel and corticos-
teroids for palliative purpose.
Conclusions
In summary, pulmonary lymphangitic carcinomatosis is a
common entity in patients with a history of breast carci-
noma. Clinical awareness and accurate diagnosis with
pathology will guide appropriate treatment and improve
the quality of life of the patients. In this patient, her dyp-
noea is highly likely to be multifactorial although che-
motherapy has significantly improved her breathing.
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